Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

An American Airlines plane with 64 people on board collided with an Army helicopter over Washington, D.C., and crashed into ...

After Judy Zweig lost her home to the Palisades fire, someone stole her husband's identity and applied fraudulently for FEMA assistance.

Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...

As an orthopedic and sports medicine surgeon and chairman at Inova Sports Medicine, Dr. Robin West is no stranger to sports-related injuries. She understands that developing an effective game plan to ...

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...

While New Orleans prepares for the excitement of the big game, it’s important to remember that sports injuries aren’t limited to the professionals. High school athletes, weekend warriors, and generall ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

The new FDA-approved pain drug is suzetrigine, with the brand name Journavx. Suzetrigine is designed to alleviate moderate to ...

(WJW) – Mother Nature brought both beauty and pain to Northern Ohio Thursday morning as the area woke up under a sheet of ice. Widespread freezing rain created spectacular images of trees lined ...

The manufacturer of AV-101, an investigational, oral nonopioid, NMDA-targeting therapy to treat neuropathic pain, announced that it has received a U.S. patent for the treatment. AV-101 (4-Cl-KYN) is ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non ...